BTL-MK
BTL-MK (Compound 19) an orally active antiallergic agent, that inhibits degranulation of mast cells with an IC50 of 6.7 μM, through binding to the inhibitory receptor FcγRIIB. BTL-MK improves the metaboilic stability in human liver microsomes. BTL-MK ameliorates the allergic response in Ovalbumins -induced food allergy mice model. BTL-MK exhibits a good pharmacokinetic character with metabolic stability[1].
Product Specifications
CAS Number
2758569-43-4
UNSPSC
12352005
Target
Fc Receptor (FcR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/btl-mk.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=C(C=C1C/C=C(C)\C)C[C@]2(OC(C(O)=C2C3=CC=C(C=C3)O)=O)C(C)=O
Molecular Formula
C24H24O6
Molecular Weight
408.44
References & Citations
[1]Xie CL, et al., Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB. J Med Chem. 2024 May 9;67 (9) :7504-7515.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![ZRANB1 Mouse Monoclonal Antibody [Clone ID: OTI2A10]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908988/imageurl/cf810024.webp)
CF810024 100 µg
ZRANB1 Mouse Monoclonal Antibody [Clone ID: OTI2A10]
Sign In for Pricing
View Details 
BNC681937-500 1x 500 µL
Vimentin (Mesenchymal Cell Marker) (VIM/1937R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
